Gołembiowska K
Unit II, Department of Pharmacology and Brain Biostructure, Maj Institute of Pharmacology, Polish Academy of Sciences, 31-343 Kraków, Smętna, Poland. Electronic address: nfgolemb@cyf-kr.edu.pl.
ArticlePsilocybin
Psilocybin restores behavioral and neuroplastic deficits induced by chronic stress in rats.
ArticlePsilocybin
Effects of psilocybin and chronic mild stress on microglial activation in rat spinal cord: an ex vivo analysis.
ArticlePsilocybin
The effect of psilocin on neurotransmitters release in the claustrum and on rat behavior.
ArticlePsilocybin
Psilocybin and ketamine affect novel neuropeptides gene expression in the rat hypothalamus.
ArticlePsilocybin
The effect of low-dose psilocybin on brain neurotransmission and rat behavior.
ArticlePsilocybin
Molecular and Medical Aspects of Psychedelics.
ArticlePsilocybin
Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study.
PreprintPsilocybin
Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study
ArticlePsilocybin
Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior.
ArticlePsychedelics
Neurotoxicological profile of the hallucinogenic compound 25I-NBOMe.
ArticlePsychedelics
Tolerance to neurochemical and behavioral effects of the hallucinogen 25I-NBOMe.
ArticleMDMA
Neurochemical and Behavioral Effects of a New Hallucinogenic Compound 25B-NBOMe in Rats.
ArticlePsychedelics
Hallucinogen-Like Action of the Novel Designer Drug 25I-NBOMe and Its Effect on Cortical Neurotransmitters in Rats.
ArticlePsychedelics